European Pharmaceutical Review

JANUARY 11, 2024

A major limitation is that these drugs generally do not target the specific causes of neuropathic pain, and their efficacy is reduced when the underlying conditions, like nerve damage, cannot be treated effectively. What are the key current challenges in the development of pain medicines? Internet] NIH. cited 2024Jan]. Internet] NIH.

Medicine 78

Medicine Pharmacology Management Side effects 78

Contrarian Sales Techniques

FEBRUARY 25, 2023

During my pharmacology class, I learned that there are no safe drugs, only safe patients. This highlights the importance of taking an individualized approach to medicine and considering a patient's unique medical history, current health status, and other relevant factors when prescribing medication.

Side effects 52

Side effects Medical sales reps Insurance Pharmacology 52

Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Pharmacology Side effects 98

PM360

NOVEMBER 29, 2022

Food and Drug Administration (FDA) or European Medicines Agency (EMA). Analyzing drug label information can provide a valuable source of competitive data for life sciences companies, enabling them to fulfill several use cases, including: Comparing labels for a class or group of drugs to assist with authoring.

Food and Drug Administration 98

Food and Drug Administration Competition Safety Pharmacology 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower side effects and enhanced treatment convenience.

Food and Drug Administration 77

Food and Drug Administration Safety Patients Leads 77

Pharmaceutical Technology

OCTOBER 10, 2022

To say two is fine and enough does a disservice to women,” states Sheryl Kingsberg, PhD, Chief of the Division of Behavioral Medicine at the University Hospitals Cleveland. Overall, side effects serve as a more significant barrier in this condition than elsewhere because the condition is not life-threatening, says Ben-Zion.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Pharmaceutical Technology

FEBRUARY 17, 2023

Most drugs being developed now are more tailored to specific mechanisms of action compared to past drugs, says Dr. Gareth Veal, PhD, a professor of cancer pharmacology at Newcastle University. The demand came amid concerns that the drug causes a slew of side effects such as nausea, diarrhea, and liver issues.

FDA 115

FDA Side effects Pharmacology Patients 115